331 related articles for article (PubMed ID: 17941829)
1. Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors.
Kurth MA; Dimichele D; Sexauer C; Sanders JM; Torres M; Zappa SC; Ragni M; Leonard N
Haemophilia; 2008 Jan; 14(1):50-5. PubMed ID: 17941829
[TBL] [Abstract][Full Text] [Related]
2. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
[TBL] [Abstract][Full Text] [Related]
3. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
Rothschild C; D'Oiron R; Borel-Derlon A; Gruel Y; Navarro R; Negrier C
Haemophilia; 2013 Mar; 19(2):281-6. PubMed ID: 23038998
[TBL] [Abstract][Full Text] [Related]
4. Immune tolerance induction using a factor VIII/von Willebrand factor concentrate (BIOSTATE), with or without immunosuppression, in Australian paediatric severe haemophilia A patients with high titre inhibitors: a multicentre, retrospective study.
Robertson JD; Higgins P; Price J; Dunkley S; Barrese G; Curtin J
Thromb Res; 2014 Nov; 134(5):1046-51. PubMed ID: 25267706
[TBL] [Abstract][Full Text] [Related]
5. Primary and rescue immune tolerance induction in children and adults: a multicentre international study with a VWF-containing plasma-derived FVIII concentrate.
Oldenburg J; Jiménez-Yuste V; Peiró-Jordán R; Aledort LM; Santagostino E
Haemophilia; 2014 Jan; 20(1):83-91. PubMed ID: 24354480
[TBL] [Abstract][Full Text] [Related]
6. The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.
Greninger DA; Saint-Remy JM; Jacquemin M; Benhida A; DiMichele DM
Haemophilia; 2008 Mar; 14(2):295-302. PubMed ID: 18081826
[TBL] [Abstract][Full Text] [Related]
7. The use of a single von Willebrand factor-containing, plasma-derived FVIII product in hemophilia A immune tolerance induction: the US experience.
Kurth M; Puetz J; Kouides P; Sanders J; Sexauer C; Bernstein J; Gruppo R; Manco-Johnson M; Neufeld EJ; Rodriguez N; Wicklund B; Quon D; Aledort L
J Thromb Haemost; 2011 Nov; 9(11):2229-34. PubMed ID: 21883884
[TBL] [Abstract][Full Text] [Related]
8. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
[TBL] [Abstract][Full Text] [Related]
9. More than a decade of international experience with a pdFVIII/VWF concentrate in immune tolerance.
Santagostino E
Haemophilia; 2013 Jan; 19 Suppl 1():8-11. PubMed ID: 23278994
[TBL] [Abstract][Full Text] [Related]
10. ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.
Oldenburg J; Austin SK; Kessler CM
Haemophilia; 2014 Sep; 20 Suppl 6():17-26. PubMed ID: 24975701
[TBL] [Abstract][Full Text] [Related]
11. A review of immune tolerance induction with Haemate P in haemophilia A.
Escuriola Ettingshausen C; Kreuz W
Haemophilia; 2014 May; 20(3):333-9. PubMed ID: 24165472
[TBL] [Abstract][Full Text] [Related]
12. Low-dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success.
Elalfy M; Elghamry I; Hassab H; Elalfy O; Andrawes N; El-Ekiaby M
Haemophilia; 2022 Jan; 28(1):65-72. PubMed ID: 34797008
[TBL] [Abstract][Full Text] [Related]
13. The role of VWF for the success of immune tolerance induction.
Kreuz W
Thromb Res; 2008; 122 Suppl 2():S7-S12. PubMed ID: 18549910
[TBL] [Abstract][Full Text] [Related]
14. Immune tolerance induction in patients with hemophilia A.
Astermark J
Thromb Res; 2011 Jan; 127 Suppl 1():S6-9. PubMed ID: 21056905
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study.
Jiménez-Yuste V; Oldenburg J; Rangarajan S; Peiró-Jordán R; Santagostino E
Haemophilia; 2016 Nov; 22(6):859-865. PubMed ID: 27329267
[TBL] [Abstract][Full Text] [Related]
16. The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture?
Ettingshausen CE; Kreuz W
Haemophilia; 2013 Jan; 19 Suppl 1():12-7. PubMed ID: 23278995
[TBL] [Abstract][Full Text] [Related]
17. Challenges of the management of severe hemophilia A with inhibitors: two case reports emphasizing the potential interest of a high-purity human Factor VIII/von Willebrand factor concentrate and individually tailored prophylaxis guided by thrombin-generation test.
Mathieu S; Crampe C; Dargaud Y; Lavigne-Lissalde G; Escuriola-Ettingshausen C; Tardy B; Meley R; Thouvenin S; Stephan JL; Berger C
Blood Coagul Fibrinolysis; 2015 Dec; 26(8):940-5. PubMed ID: 26517064
[TBL] [Abstract][Full Text] [Related]
18. New predictive approaches for ITI treatment.
Minno GD; Santagostino E; Pratt K; Königs C
Haemophilia; 2014 Sep; 20 Suppl 6():27-43. PubMed ID: 24975702
[TBL] [Abstract][Full Text] [Related]
19. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
Nakar C; Manco-Johnson MJ; Lail A; Donfield S; Maahs J; Chong Y; Blades T; Shapiro A
Haemophilia; 2015 May; 21(3):365-373. PubMed ID: 25581638
[TBL] [Abstract][Full Text] [Related]
20. Understanding FVIII/VWF complex--report from a symposium of XXIX WFH meeting 2010.
Gringeri A; Ofosu FA; Grancha S; Oldenburg J; Ewing NP; Federici AB
Haemophilia; 2012 May; 18(3):469-75. PubMed ID: 21943193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
